- Home
- Equipment
- north america
- inflammatory implantable
Refine by
Inflammatory Implantable Equipment Supplied In North America
4 equipment items found
Manufactured by:Lyra Therapeutics, Inc. based inWatertown, MASSACHUSETTS (USA)
Lyra’s lead product candidate, LYR-210, to treat chronic rhinosinusitis (CRS), an inflammatory disease of the paranasal sinuses. LYR-210 is an anti-inflammatory implantable drug matrix based upon Lyra’s XTreo™ platform designed to elute mometasone furoate consistently and locally to the inflamed mucosal tissue of ...
Manufactured by:CorMatrix, Inc. based inRoswell, GEORGIA (US) (USA)
The CorMatrix Cor PATCH is a device that has been designed to assist cardiac surgeons in those areas of repair requiring additional epicardial support of adult cardiac structures. Made of a second generation of extracellular matrix (ECM) technology the Cor PATCH can be used for sequelae secondary to myocardial infarction resulting in a thinning of ventricular walls, aneurysm formation or for any ...
Manufactured by:Elanco based inGreenfield, INDIANA (USA)
Regardless of cattle prices, it is essential to use proven and high-return solutions, like Component with Tylan. Because they provide a 24:1 return on investment (ROI), implants continue to play a significant role in end-point management ...
Manufactured by:Lyra Therapeutics, Inc. based inWatertown, MASSACHUSETTS (USA)
LYR-220, Lyra’s second product candidate, is in Phase 2 development for the millions of chronic rhinosinusitis (CRS) patients who have undergone a prior sinus surgery but continue to have persistent ...